Average Co-Inventor Count = 6.28
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (10 from 1,451 patents)
2. Sanofi-a Ventis Deutschland Gmbh (1 from 1,827 patents)
3. Sanofi-aventis (1 from 389 patents)
12 patents:
1. 9133181 - Substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
2. 8846712 - 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
3. 8796458 - Cyclohexylamine isoquinolone derivatives
4. 8722671 - Isoquinoline derivatives
5. 8686150 - 6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
6. 8609691 - Cyclohexylamin isoquinolone derivatives
7. 8541449 - Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors
8. 8524737 - Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
9. 8501736 - Isoquinoline derivatives
10. 8399482 - 6-substituted isoquinolines and isoquinolinones
11. 8188117 - Piperidinyl-substituted isoquinolone derivatives
12. 7858328 - High-throughput Enzyme-linked immuno absorbent assay (ELISA) for determination of Rho-kinase (ROK) activity